Beigene Ltd
HKEX:6160

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
HKEX:6160
Watchlist
Price: 200.6 HKD 0.96% Market Closed
Market Cap: 273.3B HKD

Wall Street
Price Targets

Price Targets Summary
Beigene Ltd

Wall Street analysts forecast Beigene Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 249.72 HKD with a low forecast of 218.34 HKD and a high forecast of 300.33 HKD.

Lowest
Price Target
218.34 HKD
9% Upside
Average
Price Target
249.72 HKD
24% Upside
Highest
Price Target
300.33 HKD
50% Upside
Beigene Ltd Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
16% Upside

Revenue
Forecast

56% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
56% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 5 years the compound annual growth rate for Beigene Ltd's revenue is 56%. The projected CAGR for the next 4 years is 21%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beigene Ltd's stock price target?
Price Target
249.72 HKD

According to Wall Street analysts, the average 1-year price target for Beigene Ltd is 249.72 HKD with a low forecast of 218.34 HKD and a high forecast of 300.33 HKD.

What is Beigene Ltd's Revenue forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for Beigene Ltd's revenue is 56%. The projected CAGR for the next 4 years is 21%.

Back to Top